{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T06:05:53Z","timestamp":1780380353376,"version":"3.54.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T00:00:00Z","timestamp":1615852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T00:00:00Z","timestamp":1615852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s00347-021-01351-2","type":"journal-article","created":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T14:06:45Z","timestamp":1615903605000},"page":"519-532","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Okul\u00e4re Beteiligung bei Stevens-Johnson-Syndrom und toxisch epidermaler Nekrolyse","Ocular involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis"],"prefix":"10.1007","volume":"118","author":[{"given":"Argyrios","family":"Chronopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Mockenhaupt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Pleyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,16]]},"reference":[{"key":"1351_CR1","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1001\/archpedi.1922.04120120077005","volume":"24","author":"AM Stevens","year":"1922","unstructured":"Stevens\u00a0AM, Johnson\u00a0FC (1922) A new eruptive fever associated with stomatitis and ophthalmia; report of two cases in children. Am J Dis Child 24:526\u2013533","journal-title":"Am J Dis Child"},{"issue":"11","key":"1351_CR2","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/j.1365-2133.1956.tb12766.x","volume":"68","author":"A Lyell","year":"1956","unstructured":"Lyell\u00a0A (1956) Toxic epidermal necrolysis: an eruption resembling scalding of the skin. Br J Dermatol 68(11):355\u2013361","journal-title":"Br J Dermatol"},{"key":"1351_CR3","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1001\/archderm.138.8.1019","volume":"138","author":"A Auquier-Dunant","year":"2002","unstructured":"Auquier-Dunant\u00a0A, Mockenhaupt\u00a0M, Naldi\u00a0L et al (2002) Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study. Arch Dermatol 138:1019\u20131024","journal-title":"Arch Dermatol"},{"key":"1351_CR4","first-page":"733","volume-title":"Fitzpatrick\u2019s dermatology","author":"M Mockenhaupt","year":"2019","unstructured":"Mockenhaupt\u00a0M, Roujeau\u00a0JC (2019) Epidermal necrolysis (Stevens-Johnson syndrome and toxic epidermal necrolysis). In: Kang\u00a0S, Amagai\u00a0M, Bruckner\u00a0A, Enk\u00a0AH, Margolis\u00a0DJ, McMichael\u00a0AJ, Orringer\u00a0JS (Hrsg) Fitzpatrick\u2019s dermatology, 9.\u00a0Aufl. McGraw-Hill, New York, S 733\u2013748","edition":"9"},{"key":"1351_CR5","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1097\/ICO.0000000000000646","volume":"34","author":"ML White","year":"2015","unstructured":"White\u00a0ML, Chodosh\u00a0J, Jang\u00a0J et al (2015) Incidence of Stevens-Johnson syndrome and chemical burns to the eye. Cornea 34:1527\u20131153","journal-title":"Cornea"},{"key":"1351_CR6","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1097\/01.BCR.0000150215.78220.79","volume":"26","author":"J Haber","year":"2005","unstructured":"Haber\u00a0J, Hopman\u00a0W, Gomez\u00a0M et\u00a0al (2005) Late outcomes in adult survivors of toxic epidermal necrolysis after treatment in a\u00a0burn center. J\u00a0Burn Care Rehabil 26:33\u201341","journal-title":"J Burn Care Rehabil"},{"key":"1351_CR7","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","volume":"129","author":"S Bastuji-Garin","year":"1993","unstructured":"Bastuji-Garin\u00a0S, Rzany\u00a0B, Stern\u00a0RS et al (1993) Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 129:92\u201396","journal-title":"Arch Dermatol"},{"key":"1351_CR8","first-page":"148","volume-title":"Entz\u00fcndliche Augenerkrankungen","author":"A Chronopoulos","year":"2014","unstructured":"Chronopoulos\u00a0A, Mockenhaupt\u00a0M, Pleyer\u00a0U (2014) Okul\u00e4re Beteiligung bei Stevens-Johnson-Syndrom (SJS) und Toxisch epidermaler Nekrolyse (TEN). In: Pleyer\u00a0U (Hrsg) Entz\u00fcndliche Augenerkrankungen. Springer, Berlin, S 148\u2013157"},{"key":"1351_CR9","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s00105-018-4176-8","volume":"69","author":"M Mockenhaupt","year":"2018","unstructured":"Mockenhaupt\u00a0M (2018) Akute, lebensbedrohliche Medikamentenreaktionen der Haut. Hautarzt 69:364\u2013375","journal-title":"Hautarzt"},{"key":"1351_CR10","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1046\/j.1523-1747.2000.00061.x","volume":"115","author":"S Bastuji-Garin","year":"2000","unstructured":"Bastuji-Garin\u00a0S, Fouchard\u00a0N, Bertocchi\u00a0M et al (2000) SCORTEN: a\u00a0severity-of-illness score for toxic epidermal necrolysis. J\u00a0Invest Dermatol 115:149\u2013153","journal-title":"J Invest Dermatol"},{"key":"1351_CR11","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1016\/j.jid.2020.03.968","volume":"140","author":"D Naegele","year":"2020","unstructured":"Naegele\u00a0D, Sekula\u00a0P, Paulmann\u00a0M, Mockenhaupt\u00a0M (2020) Incidence of epidermal necrolysis: results of the German registry. J\u00a0Invest Dermatol 140:2525\u20132527. https:\/\/doi.org\/10.1016\/j.jid.2020.03.968","journal-title":"J Invest Dermatol"},{"key":"1351_CR12","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/ICO.0b013e31802eb264","volume":"26","author":"YS Chang","year":"2007","unstructured":"Chang\u00a0YS, Huang\u00a0FC, Tseng\u00a0SH et al (2007) Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management. Cornea 26:123\u2013129","journal-title":"Cornea"},{"key":"1351_CR13","doi-asserted-by":"publisher","first-page":"adv00057","DOI":"10.2340\/00015555-3408","volume":"100","author":"M Mockenhaupt","year":"2020","unstructured":"Mockenhaupt\u00a0M (2020) Bullous drug reactions. Acta Derm Venereol 100:adv57. https:\/\/doi.org\/10.2340\/00015555-3408","journal-title":"Acta Derm Venereol"},{"issue":"10","key":"1351_CR14","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00105-017-4048-7","volume":"68","author":"M Mockenhaupt","year":"2017","unstructured":"Mockenhaupt\u00a0M (2017) Schwere kutane Arzneimittelreaktionen im Kindesalter. Hautarzt 68(10):803\u2013814","journal-title":"Hautarzt"},{"issue":"1","key":"1351_CR15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/sj.jid.5701033","volume":"128","author":"M Mockenhaupt","year":"2008","unstructured":"Mockenhaupt\u00a0M, Viboud\u00a0C, Dunant\u00a0A et al (2008) Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. J\u00a0Invest Dermatol 128(1):35\u201344","journal-title":"J Invest Dermatol"},{"key":"1351_CR16","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1097\/ACI.0000000000000546","volume":"19","author":"MR Ardern-Jones","year":"2019","unstructured":"Ardern-Jones\u00a0MR, Mockenhaupt\u00a0M (2019) Making a\u00a0diagnosis in severe cutaneous drug hypersensitivity reactions. Curr Opin Allergy Clin Immunol 19:283\u2013293","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"1351_CR17","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1038\/nm.1884","volume":"14","author":"WH Chung","year":"2008","unstructured":"Chung\u00a0WH, Hung\u00a0SI, Yang\u00a0JY et al (2008) Granulysin is a\u00a0key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis. Nat Med 14:1343\u20131350","journal-title":"Nat Med"},{"key":"1351_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2020.09.048","author":"CB Chen","year":"2020","unstructured":"Chen\u00a0CB, Kuo\u00a0KL, Wang\u00a0CW, Taiwan Severe Cutaneous Adverse Reaction Consortium et al (2020) Detecting lesional granulysin levels for rapid diagnosis of cytotoxic T lymphocyte-mediated bullous skin disorders. J\u00a0Allergy Clin Immunol Pract. https:\/\/doi.org\/10.1016\/j.jaip.2020.09.048","journal-title":"J Allergy Clin Immunol Pract"},{"key":"1351_CR19","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1001\/archderm.1987.01660330082014","volume":"123","author":"JC Roujeau","year":"1987","unstructured":"Roujeau\u00a0JC, Huynh\u00a0TN, Bracq\u00a0C et\u00a0al (1987) Genetic susceptibility to toxic epidermal necrolysis. Arch Dermatol 123:1171\u20131173","journal-title":"Arch Dermatol"},{"key":"1351_CR20","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/sj.tpj.6500356","volume":"6","author":"C Lonjou","year":"2006","unstructured":"Lonjou\u00a0C, Thomas\u00a0L, Borot\u00a0N et al (2006) A marker for Stevens-Johnson syndrome\u00a0\u2026: ethnicity matters. Pharmacogenomics\u00a0J 6:265\u2013268","journal-title":"Pharmacogenomics J"},{"issue":"11","key":"1351_CR21","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1111\/all.13821","volume":"74","author":"M Mockenhaupt","year":"2019","unstructured":"Mockenhaupt\u00a0M, Wang\u00a0CW, Hung\u00a0SI, RegiSCAR group et al (2019) HLA-B*57:01 confers genetic susceptibility to carbamazepine-induced SJS\/TEN in Europeans. Allergy 74(11):2227\u20132230","journal-title":"Allergy"},{"key":"1351_CR22","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/FPC.0b013e3282f3ef9c","volume":"18","author":"C Lonjou","year":"2008","unstructured":"Lonjou\u00a0C, Borot\u00a0N, Sekula\u00a0P et al (2008) A European study of HLA\u2011B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs. Pharmacogenet Genomics 18:99\u2013107","journal-title":"Pharmacogenet Genomics"},{"issue":"1","key":"1351_CR23","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jdermsci.2020.02.003","volume":"98","author":"WC Chang","year":"2020","unstructured":"Chang\u00a0WC, Abe\u00a0R, Anderson\u00a0P et\u00a0al (2020) From science to translation. J\u00a0Dermatol Sci 98(1):2\u201312. https:\/\/doi.org\/10.1016\/j.jdermsci.2020.02.003","journal-title":"J Dermatol Sci"},{"key":"1351_CR24","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s40629-019-00111-8","volume":"28","author":"M Paulmann","year":"2019","unstructured":"Paulmann\u00a0M, Mockenhaupt\u00a0M (2019) Schwere Hautreaktionen: klinisches Bild, Epidemiologie, \u00c4tiologie, Pathogenese und Therapie. Allergo J Int 28:311\u2013326","journal-title":"Allergo J Int"},{"key":"1351_CR25","volume-title":"Skin biopsy","author":"M Ziemer","year":"2011","unstructured":"Ziemer\u00a0M, Mockenhaupt\u00a0M (2011) Severe drug-induced skin reactions: clinical pattern, diagnostics and therapy. In: Khopkar\u00a0U (Hrsg) Skin biopsy"},{"key":"1351_CR26","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jtos.2015.10.002","volume":"14","author":"S Kohanim","year":"2016","unstructured":"Kohanim\u00a0S, Palioura\u00a0S, Saeed\u00a0HN et al (2016) Stevens-Johnson syndrome\/toxic epidermal necrolysis\u2014a comprehensive review and guide to therapy. I. Systemic disease. Ocul Surf 14:2\u201319","journal-title":"Ocul Surf"},{"key":"1351_CR27","doi-asserted-by":"publisher","first-page":"e16155","DOI":"10.1097\/MD.0000000000016155","volume":"98","author":"T Shrestha","year":"2019","unstructured":"Shrestha\u00a0T, Moon\u00a0HS, Choi\u00a0W et al (2019) Characteristics of meibomian gland dysfunction in patients with Stevens-Johnson syndrome. Medicine 98:e16155","journal-title":"Medicine"},{"key":"1351_CR28","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1016\/j.ophtha.2016.04.041","volume":"123","author":"DG Gregory","year":"2016","unstructured":"Gregory\u00a0DG (2016) New grading system and treatment guidelines for the acute ocular manifestations of Stevens-Johnson syndrome. Ophthalmology 123:1653\u20131658","journal-title":"Ophthalmology"},{"key":"1351_CR29","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.ophtha.2006.10.029","volume":"114","author":"C Sotozono","year":"2007","unstructured":"Sotozono\u00a0C, Ang\u00a0LP, Koizumi\u00a0N et al (2007) New grading system for the evaluation of chronic ocular manifestations in patients with Stevens-Johnson syndrome. Ophthalmology 114:1294\u20131302","journal-title":"Ophthalmology"},{"key":"1351_CR30","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1136\/bjo.2006.109124","volume":"91","author":"MV De Rojas","year":"2007","unstructured":"De Rojas\u00a0MV, Dart\u00a0JK, Saw\u00a0VP (2007) The natural history of Stevens Johnson syndrome: patterns of chronic ocular disease and the role of systemic immunosuppressive therapy. Br J Ophthalmol 91:1048\u20131053","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"1351_CR31","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/bjd.12125","volume":"168","author":"A Barbaud","year":"2013","unstructured":"Barbaud\u00a0A, Collet\u00a0E, Milpied\u00a0B et\u00a0al (2013) Toxidermies group of the French society of dermatology. A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions. Br J Dermatol 168(3):555\u2013562","journal-title":"Br J Dermatol"},{"key":"1351_CR32","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1111\/bjd.14530","volume":"174","author":"D Creamer","year":"2016","unstructured":"Creamer\u00a0D, Walsh\u00a0SA, Dziewulski\u00a0P et al (2016) U.K. guidelines for the management of Stevens-Johnson syndrome\/toxic epidermal necrolysis in adults 2016. Br J Dermatol 174:1194\u20131227","journal-title":"Br J Dermatol"},{"issue":"2","key":"1351_CR33","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4103\/ijd.IJD_583_17","volume":"63","author":"R Kumar","year":"2018","unstructured":"Kumar\u00a0R, Das\u00a0A, Das\u00a0S (2018) Management of Stevens-Johnson syndrome-toxic epidermal necrolysis: looking beyond guidelines! Indian J Dermatol 63(2):117\u2013124","journal-title":"Indian J Dermatol"},{"key":"1351_CR34","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1001\/jamadermatol.2016.5668","volume":"153","author":"S Zimmermann","year":"2017","unstructured":"Zimmermann\u00a0S, Sekula\u00a0P, Venhoff\u00a0M et al (2017) Systemic immunomodulating therapies for Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis. JAMA Dermatol 153:514\u2013522","journal-title":"JAMA Dermatol"},{"key":"1351_CR35","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.2165\/00003495-200565150-00002","volume":"65","author":"O Faye","year":"2005","unstructured":"Faye\u00a0O, Roujeau\u00a0JC (2005) Treatment of epidermal necrolysis with high-dose intravenous immunoglobulins (IVIG). Clinical experience to date. Drugs 65:2085\u20132090","journal-title":"Drugs"},{"key":"1351_CR36","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1111\/j.1365-2133.2012.10965.x","volume":"167","author":"YC Huang","year":"2012","unstructured":"Huang\u00a0YC, Li\u00a0YC, Chen\u00a0TJ (2012) The efficacy of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis: a\u00a0systematic review and meta-analysis. Br J Dermatol 167:424\u2013432","journal-title":"Br J Dermatol"},{"key":"1351_CR37","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1172\/JCI93349","volume":"128","author":"CW Wang","year":"2018","unstructured":"Wang\u00a0CW, Yang\u00a0LY, Chen\u00a0CB et al (2018) Randomized, controlled trial of TNF\u2011\u03b1 antagonist in CTL-mediated severe cutaneous adverse reactions. J\u00a0Clin Invest 128:985\u2013986","journal-title":"J Clin Invest"},{"key":"1351_CR38","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005373-200003000-00017","volume":"48","author":"JM Arevalo","year":"2000","unstructured":"Arevalo\u00a0JM, Lorente\u00a0JA, Gonzalez-Herrada\u00a0C et al (2000) Treatment of toxic epidermal necrolysis with cyclosporin A. J\u00a0Trauma 48:473\u2013478","journal-title":"J Trauma"},{"key":"1351_CR39","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1111\/j.1365-2133.2010.09863.x","volume":"163","author":"L Valeyrie-Allanore","year":"2010","unstructured":"Valeyrie-Allanore\u00a0L, Wolkenstein\u00a0P, Brochard\u00a0L et al (2010) Open trial of ciclosporin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis. Br J Dermatol 163:847\u2013853","journal-title":"Br J Dermatol"},{"key":"1351_CR40","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1016\/j.jid.2017.05.022","volume":"137","author":"C Gonz\u00e1lez-Herrada","year":"2017","unstructured":"Gonz\u00e1lez-Herrada\u00a0C, Rodr\u00edguez-Mart\u00edn\u00a0S, Cachafeiro\u00a0L et al (2017) Cyclosporine use in epidermal necrolysis is associated with an important mortality reduction: evidence from three different approaches. J\u00a0Invest Dermatol 137:2092\u20132100","journal-title":"J Invest Dermatol"},{"key":"1351_CR41","doi-asserted-by":"publisher","first-page":"135","DOI":"10.2147\/JIR.S160964","volume":"11","author":"QX Ng","year":"2018","unstructured":"Ng\u00a0QX, De Deyn\u00a0MLZQ, Venkatanarayanan\u00a0N et al (2018) A meta-analysis of cyclosporine treatment for Stevens-Johnson syndrome\/toxic epidermal necrolysis. JIR 11:135\u2013142","journal-title":"JIR"},{"key":"1351_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2020.05.003","author":"LN Hall","year":"2020","unstructured":"Hall\u00a0LN, Shanbhag\u00a0SS, Rashad\u00a0R, Chodosh\u00a0J, Saeed\u00a0HN (2020) The effects of systemic cyclosporine in acute Stevens-Johnson syndrome\/toxic epidermal necrolysis on ocular disease. Ocul Surf. https:\/\/doi.org\/10.1016\/j.jtos.2020.05.003","journal-title":"Ocul Surf"},{"key":"1351_CR43","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ajo.2015.05.002","volume":"160","author":"C Sotozono","year":"2015","unstructured":"Sotozono\u00a0C, Ueta\u00a0M, Nakatani\u00a0E et al (2015) Predictive factors associated with acute ocular involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis. Am J Ophthalmol 160:228\u2013237.e2","journal-title":"Am J Ophthalmol"},{"key":"1351_CR44","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jtos.2019.10.010","volume":"18","author":"HS Ong","year":"2020","unstructured":"Ong\u00a0HS, Minassian\u00a0D, Rauz\u00a0S et\u00a0al (2020) Validation of a\u00a0clinical assessment tool for cicatrising conjunctivitis. Ocul Surf 18:121\u2013129","journal-title":"Ocul Surf"},{"key":"1351_CR45","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1089\/jop.2012.0009","volume":"29","author":"P Prabhasawat","year":"2013","unstructured":"Prabhasawat\u00a0P, Tesavibul\u00a0N, Karnchanachetanee\u00a0C et\u00a0al (2013) Efficacy of cyclosporine 0.05\u202f% eye drops in Stevens Johnson syndrome with chronic dry eye. J\u00a0Ocul Pharmacol Ther 29:372\u2013377","journal-title":"J Ocul Pharmacol Ther"},{"key":"1351_CR46","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jtos.2014.12.006","volume":"13","author":"KH Wan","year":"2015","unstructured":"Wan\u00a0KH, Chen\u00a0LJ, Young\u00a0AL (2015) Efficacy and safety of topical 0.05\u202f% cyclosporine eye drops in the treatment of dry eye syndrome: a systematic review and meta-analysis. Ocul Surf 13:213\u2013225","journal-title":"Ocul Surf"},{"key":"1351_CR47","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1097\/ICO.0000000000001960","volume":"38","author":"N Sharma","year":"2019","unstructured":"Sharma\u00a0N, Venugopal\u00a0R, Singhal\u00a0D et al (2019) Microbial keratitis in Stevens-Johnson syndrome: a prospective study. Cornea 38:938\u2013942","journal-title":"Cornea"},{"key":"1351_CR48","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.jtos.2018.07.002","volume":"16","author":"B Bagga","year":"2018","unstructured":"Bagga\u00a0B, Motukupally\u00a0SR, Mohamed\u00a0A (2018) Microbial keratitis in Stevens-Johnson syndrome: clinical and microbiological profile. Ocul Surf 16:454\u2013457","journal-title":"Ocul Surf"},{"issue":"6","key":"1351_CR49","doi-asserted-by":"publisher","first-page":"658","DOI":"10.5301\/ejo.5000923","volume":"27","author":"A Pinna","year":"2017","unstructured":"Pinna\u00a0A, Nuvoli\u00a0E, Blasetti\u00a0F, Posadinu\u00a0MA, Boscia\u00a0F (2017) Plasmapheresis, intravenous immunoglobulins, and autologous serum eyedrops in the acute eye complications of toxic epidermal necrolysis. Eur J Ophthalmol 27(6):658\u2013663","journal-title":"Eur J Ophthalmol"},{"key":"1351_CR50","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.ophtha.2015.10.027","volume":"123","author":"N Sharma","year":"2016","unstructured":"Sharma\u00a0N, Thenarasun\u00a0SA, Kaur\u00a0M et al (2016) Adjuvant role of amniotic membrane transplantation in acute ocular Stevens-Johnson syndrome: a randomized control trial. Ophthalmology 123:484\u2013491","journal-title":"Ophthalmology"},{"key":"1351_CR51","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.jtos.2020.03.004","volume":"18","author":"SS Shanbhag","year":"2020","unstructured":"Shanbhag\u00a0SS, Hall\u00a0L, Chodosh\u00a0J et al (2020) Long-term outcomes of amniotic membrane treatment in acute Stevens-Johnson syndrome\/toxic epidermal necrolysis. Ocul Surf 18:517\u2013522","journal-title":"Ocul Surf"},{"key":"1351_CR52","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.ajo.2019.07.006","volume":"208","author":"SS Shanbhag","year":"2019","unstructured":"Shanbhag\u00a0SS, Rashad\u00a0R, Chodosh\u00a0J et al (2019) Long-term effect of a\u00a0treatment protocol for acute ocular involvement in Stevens-Johnson syndrome\/toxic epidermal necrolysis. Am J Ophthalmol 208:331\u2013341","journal-title":"Am J Ophthalmol"},{"key":"1351_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajo.2018.10.016","volume":"199","author":"SH Choi","year":"2019","unstructured":"Choi\u00a0SH, Kim\u00a0MK, Oh\u00a0JY (2019) Corneal limbal stem cell deficiency in children with Stevens-Johnson syndrome. Am J Ophthalmol 199:1\u20138. https:\/\/doi.org\/10.1016\/j.ajo.2018.10.016","journal-title":"Am J Ophthalmol"},{"issue":"15","key":"1351_CR54","doi-asserted-by":"publisher","first-page":"e130","DOI":"10.3346\/jkms.2020.35.e130","volume":"35","author":"SY Park","year":"2020","unstructured":"Park\u00a0SY, Oh\u00a0IY, Kim\u00a0JH et al (2020) Therapeutic effects of mesenchymal stem cells on a\u00a0Stevens-Johnson syndrome\/toxic epidermal necrolysis model. J\u00a0Korean Med Sci 35(15):e130. https:\/\/doi.org\/10.3346\/jkms.2020.35.e130","journal-title":"J Korean Med Sci"},{"key":"1351_CR55","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.ajo.2009.07.006","volume":"148","author":"B Tougeron-Brousseau","year":"2009","unstructured":"Tougeron-Brousseau\u00a0B, Delcampe\u00a0A, Gueudry\u00a0J et al (2009) Vision-related function after scleral lens fitting in ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis. Am J Ophthalmol 148:852\u2013859.e2","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"1351_CR56","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1136\/bjophthalmol-2019-315345","volume":"104","author":"AA Szigiato","year":"2020","unstructured":"Szigiato\u00a0AA, Bostan\u00a0C, Nayman\u00a0T, Harissi-Dagher\u00a0M (2020) Long-term visual outcomes of the Boston type I keratoprosthesis in Canada. Br J Ophthalmol 104(11):1601\u20131607. https:\/\/doi.org\/10.1136\/bjophthalmol-2019-315345","journal-title":"Br J Ophthalmol"},{"issue":"11","key":"1351_CR57","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.4103\/ijo.IJO_604_20","volume":"68","author":"J Vazirani","year":"2020","unstructured":"Vazirani\u00a0J, Donthineni\u00a0PR, Goel\u00a0S et\u00a0al (2020) Chronic cicatrizing conjunctivitis: a review of the differential diagnosis and an algorithmic approach to management. Indian J Ophthalmol 68(11):2349\u20132355. https:\/\/doi.org\/10.4103\/ijo.IJO_604_20","journal-title":"Indian J Ophthalmol"},{"issue":"6","key":"1351_CR58","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/ddg.14118_g","volume":"18","author":"P Gr\u00fcnwald","year":"2020","unstructured":"Gr\u00fcnwald\u00a0P, Mockenhaupt\u00a0M, Panzer\u00a0R, Emmert\u00a0S (2020) Erythema exsudativum multiforme, Stevens-Johnson-Syndrom\/toxische epidermale Nekrolyse \u2013 Diagnostik und Therapie. Minireview. J Dtsch Dermatol Ges 18(6):547\u2013553. https:\/\/doi.org\/10.1111\/ddg.14118_g","journal-title":"J. Dtsch. Dermatol. Ges."}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-021-01351-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00347-021-01351-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-021-01351-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T02:25:33Z","timestamp":1724639133000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00347-021-01351-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,16]]},"references-count":58,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["1351"],"URL":"https:\/\/doi.org\/10.1007\/s00347-021-01351-2","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,16]]},"assertion":[{"value":"9 February 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>A.\u00a0Chronopoulos<\/b>: A.\u00a0Finanzielle Interessen: Referentenhonorar oder Kostenerstattung als passiver Teilnehmer: Allergan, Novartis.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Leitender Oberarzt, Refraktive Chirurgie, Netzhaut, Augenklinik, Klinikum Ludwigshafen. <b>M.\u00a0Mockenhaupt<\/b>: A.\u00a0Finanzielle Interessen: Erstattung der Reisekosten f\u00fcr Vortr\u00e4ge zum Thema \u201eSchwere Hautreaktionen, Arzneimittelreaktionen der Haut\u201c, in Einzelf\u00e4llen auch Honorar bis maximal 1000\u202f\u20ac (inklusive Erstattung der Reisekosten).\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Gesch\u00e4ftsf\u00fchrende Ober\u00e4rztin, Klinik f\u00fcr Dermatologie und Venerologie, Leiterin des Dokumentationszentrums schwerer Hautreaktionen (dZh), Universit\u00e4tsklinikum Freiburg, Koordinatorin des internationalen RegiSCAR-Projekts | Mitgliedschaften: Arzneimittelkommission der Deutschen \u00c4rzteschaft (AKd\u00c4, au\u00dferordentliches Mitglied), UAW-Ausschuss der AKd\u00c4, Section Editor von UpToDate Dermatology (Wolters Kluwer Health), Section: Drug Eruptions, Advisory Board of Acta Dermato-Venereologica, Forum Allergologie der Deutschen Dermatologischen Gesellschaft, Editorial Board: Dermatologica Sinica, Journal der Taiwanese Dermatological Association and Taiwanese Society for Investigative Dermatology, ad hoc Gutachterin f\u00fcr verschiedene internationale medizinische Fachzeitschriften. <b>U.\u00a0Pleyer<\/b>: A.\u00a0Finanzielle Interessen: Forschungsf\u00f6rderung zur pers\u00f6nlichen Verf\u00fcgung: Deutsche Forschungsgemeinschaft, BMBF, European Union.\u00a0\u2013 Referentenhonorar oder Kostenerstattung als passiver Teilnehmer: AbbVie, Alcon, Allergan, Alimera, Bausch und Lomb, Bayer, Novartis, Santen, Thea.\u00a0\u2013 Patente, Gesch\u00e4ftsanteile, Aktien o.\u202f\u00c4. an einer im Medizinbereich aktiven Firma: Bayer; Biontech (Aktien); Carl Zeiss | Patentanmeldung | EP 19732357.9\u00a0\u2013 PCT\/EP2019\/066419\u00a0\u2013 | COMPLEMENT ANAPHYLATOXIN BINDERS AND THEIR USE IN TREATMENT\u00a0\u2026\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Oberarzt der Klinik f\u00fcr Augenheilkunde, Charit\u00e9 Universit\u00e4tsmedizin Berlin; Mitgliedschaft\/Funktion in Interessenverb\u00e4nden: Sprecher der Sektion: Uveitis\/DOG; Schwerpunkt wissenschaftlicher klinischer T\u00e4tigkeiten\u00a0\u2013 Leiter der Sprechstunde \u201eTerti\u00e4rzentrum f\u00fcr entz\u00fcndliche Augenerkrankungen\u201c 1994 bis heute; Sekret\u00e4r: Berlin-Brandenburgische Augen\u00e4rzte, Vorstandsmitglied: Deutsche UVEITIS Arbeitsgemeinschaft DUAG e.\u202fV.; Editor und Section Editor zahlreicher ophthalmologischer Zeitschriften u.\u202fa. Acta Ophthalmologica\u00a0\u2013 Journal of Ophthalmic Inflammation and Infection\u00a0\u2013 Ophthalmologica\u00a0\u2013 Der Ophthalmologe\u00a0\u2013 Ophthalmic Research\u00a0\u2013 Progress in Retinal and Eye Research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patienten zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}